Follow the 네이처셀 share price and the full insider trade history of the company, a listed equity based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 네이처셀 has published 42 insider filings. Market capitalisation: €2,061.9bn. The latest transaction was filed on 27 March 2026 (Purchase). Among the most active insiders: 라정찬. The full history is free.
42
Insider Decl.
0
Thresholds
€1m
13 ops.
Buy Volume
·
1 ops.
Sell Volume
30Σ signal
Buys €1m· Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 19,653 of 26,270 companies
34.8
score / 100
Value
32
Quality
38
FCF yld-1.1%
Earn yld-0.2%
EV/EBITDA·
ROE·
Gross mgn46%
Net mgn-14%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.